Literature DB >> 33058017

NSAID-enteropathy and intestinal microbes.

Ingvar Bjarnason1, K D Rainsford2.   

Abstract

Entities:  

Keywords:  Enteropathy; Intestinal microbiome; NSAID; Pathogenesis of NSAID-enteropathy; Small bowel damage

Year:  2020        PMID： 33058017     DOI： 10.1007/s10787-020-00766-8

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN： 0925-4692            Impact factor:   4.473


× No keyword cloud information.
  4 in total

1.  Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.

Authors:  Carmelo Scarpignato; Werner Dolak; Angel Lanas; Peter Matzneller; Cecilia Renzulli; Maria Grimaldi; Markus Zeitlinger; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2016-12-19       Impact factor: 22.682

2.  The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial.

Authors:  Zlatan Mujagic; Paul de Vos; Mark V Boekschoten; Coen Govers; Harm-Jan H M Pieters; Nicole J W de Wit; Peter A Bron; Ad A M Masclee; Freddy J Troost
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

Review 3.  Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria.

Authors:  Elizabeth A Kennedy; Katherine Y King; Megan T Baldridge
Journal:  Front Physiol       Date:  2018-10-31       Impact factor: 4.566
  4 in total
  1 in total

1.  Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.

Authors:  Bruna Lo Sasso; Rosaria Vincenza Giglio; Matteo Vidali; Concetta Scazzone; Giulia Bivona; Caterina Maria Gambino; Anna Maria Ciaccio; Luisa Agnello; Marcello Ciaccio
Journal:  Diagnostics (Basel)       Date:  2021-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.